Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RIGL · against 496 other Healthcare companies of similar size
Ranked #330 of 497 · scores higher than 34% of peers · safety percentile 38
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)42 peers with a safety percentile of 30–39, including RIGL · Click a bar to see the companies
A mix: stronger debt / equity, but weaker beta and current ratio than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RIGL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 464 reported | 0.09× | 0.18× | 62% | 33% | |
| BetaLower is better · 470 reported | 1.20 | 0.45 | 17% | 33% | |
| Current ratioHigher is better · 486 reported | 1.94× | 2.85× | 35% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 1.2B USD | 99 | ||
| 326 | 148.7B INR (≈$1.8B) | 39 | 48 | |
| 327 | 57.0B INR (≈$684M) | 39 | 40 | |
| 328 | 672.6B KRW (≈$484M) | 39 | 69 | |
| 329 | 12.8B CNY (≈$1.8B) | 39 | 36 | |
| 330 | 913M USD | 38 | 77 | |
| 331 | 7.1B CNY (≈$998M) | 38 | 56 | |
| 332 | 14.8B MXN (≈$800M) | 38 | 61 | |
| 333 | 3.7B CNY (≈$524M) | 38 | 54 | |
| 334 | 1.6B USD | 37 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score